RT @canibagthat: Agree that HES has no role when there’s no proven benefit and there’s signal for harm. Not to mention the opportunity cost…
RT @CJA_Journal: Re-framing the question: Should hydroxyethyl starch be used in clinical practice? https://t.co/HdqDVFa1hZ #CJA #Editorial…
RT @dgriesdale: Well said @AlexisTurgeon_ and Dr. Zarynchanski. Hard to justify use of HES when there is lack of benefit and attributable h…
RT @dgriesdale: Well said @AlexisTurgeon_ and Dr. Zarynchanski. Hard to justify use of HES when there is lack of benefit and attributable h…
RT @CJA_Journal: Re-framing the question: Should hydroxyethyl starch be used in clinical practice? https://t.co/HdqDVFa1hZ #CJA #Editorial…
Agree that HES has no role when there’s no proven benefit and there’s signal for harm. Not to mention the opportunity costs of not treating bleeding appropriately.
Well said @AlexisTurgeon_ and Dr. Zarynchanski. Hard to justify use of HES when there is lack of benefit and attributable harm. @CJA_Journal
RT @CJA_Journal: Re-framing the question: Should hydroxyethyl starch be used in clinical practice? https://t.co/HdqDVFa1hZ #CJA #Editorial…
Re-framing the question: Should hydroxyethyl starch be used in clinical practice? https://t.co/HdqDVFa1hZ #CJA #Editorial @CCNT_ULAVAL https://t.co/oZpfcRG8Eu
RT @CJA_Journal: Re-framing the question: Should hydroxyethyl starch be used in clinical practice? https://t.co/HdqDVFa1hZ #CJA2019 #Editor…
Re-framing the question: Should hydroxyethyl starch be used in clinical practice? https://t.co/HdqDVFa1hZ #CJA2019 #Editorial @CCNT_ULAVAL https://t.co/er0lFZJnBU
Dr. Stuart McCluskey will be discussing the latest evidence on Fluid Administration on Sunday Feb 3. https://t.co/AwzGE2SAGV
The 1M $ question Will continue
Re-framing the question: Should hydroxyethyl starch be used in clinical practice? https://t.co/HdqDVFa1hZ #CJA2019 #CJA #Editorial @CCNT_ULAVAL https://t.co/1OgjvBdMrf